Citations (55)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Mohammed Abdulabbas Hasan, Syam Mohan, Heshu Sulaiman Rahman, Hemn Hasan Othman, Shirwan Hamasalih Omer & Abdullah Farasani. (2023) The sub-acute toxicity of kavalactone in rats: a study of the effect of oral doses and the mechanism of toxicity in combination with ethanol. Drug and Chemical Toxicology 46:3, pages 588-596.
Read now
Read now
Lei Guo, Nan Mei, Qingsu Xia, Tao Chen, Po-Chuen Chan & PeterP. Fu. (2010) Gene Expression Profiling as an Initial Approach for Mechanistic Studies of Toxicity and Tumorigenicity of Herbal Plants and Herbal Dietary Supplements. Journal of Environmental Science and Health, Part C 28:1, pages 60-87.
Read now
Read now
PeterP. Fu, Qingsu Xia, Lei Guo, Hongtao Yu & Po-Chuen Chan. (2008) Toxicity of Kava Kava. Journal of Environmental Science and Health, Part C 26:1, pages 89-112.
Read now
Read now
Amy C. Brown, Janet Onopa, Peter Holck, Pakieli Kaufusi, Derek Kabasawa, Winston J. Craig, Klaus Dragull, Arieh M. Levine & Jonathan D. Baker. (2007) Traditional kava beverage consumption and liver function tests in a predominantly Tongan population in Hawaii. Clinical Toxicology 45:5, pages 549-556.
Read now
Read now
Catherine Ulbricht, Ethan Basch, Heather Boon, Edzard Ernst, Paul Hammerness, David Sollars, Candy Tsourounis, Jen Woods & Stephen Bent. (2005) Safety review of kava (Piper methysticum) by the Natural Standard Research Collaboration. Expert Opinion on Drug Safety 4:4, pages 779-794.
Read now
Read now
Articles from other publishers (50)
Jerome Sarris, Patricia L. Gerbarg, Richard P. Brown & Philip R. Muskin. 2020. Tasman’s Psychiatry. Tasman’s Psychiatry
1
59
.
Nan Mei, Tao Chen, Baitang Ning & Lei Guo. 2021. Nutraceuticals. Nutraceuticals
299
313
.
Pietro Brunetti, Alfredo Fabrizio Lo Faro, Anastasio Tini, Francesco Paolo Busardò & Jeremy Carlier. (2020) Pharmacology of Herbal Sexual Enhancers: A Review of Psychiatric and Neurological Adverse Effects. Pharmaceuticals 13:10, pages 309.
Crossref
Crossref
Jin Xu, Mohammad Hassan-Ally, Ana María Casas-Ferreira, Tommi Suvitaival, Yun Ma, Hector Vilca-Melendez, Mohamed Rela, Nigel Heaton, Wayel Jassem & Cristina Legido-Quigley. (2020) Deregulation of the Purine Pathway in Pre-Transplant Liver Biopsies Is Associated with Graft Function and Survival after Transplantation. Journal of Clinical Medicine 9:3, pages 711.
Crossref
Crossref
Esala Vakamacawai, Eddie McCaig, Ifereimi Waqainabete & Michael R. Cox. (2019) Amoebic Liver Abscesses in Fiji: Epidemiology, Clinical Presentation and Comparison of Percutaneous Aspiration and Percutaneous Catheter Drainage. World Journal of Surgery 44:3, pages 665-672.
Crossref
Crossref
S. Christina Joycee, S. Santhana Prabha, Suresh Jancyrani, S. Senthil Kumaran, B. Narayanaswamy & Susai Rajendran. 2020. Nanotechnology in the Beverage Industry. Nanotechnology in the Beverage Industry
657
668
.
V. Lebot. (2018) Recent advances in the quality control of kava, the traditional beverage of the Pacific Islands. Acta Horticulturae:1205, pages 483-492.
Crossref
Crossref
Eric Yarnell. (2018) Herbs for Anxiety. Alternative and Complementary Therapies 24:2, pages 91-98.
Crossref
Crossref
Tiphaine Lhuissier, Pierre-Edouard Mercier, Serge Michalet, Vincent Lebot & Laurent Legendre. (2017) Colorimetric assessment of kava ( Piper methysticum Forst.) quality. Journal of Food Composition and Analysis 59, pages 27-34.
Crossref
Crossref
Nan Mei, Jiekun Xuan, Tao Chen, Baitang Ning & Lei Guo. 2016. Nutraceuticals. Nutraceuticals
249
262
.
T. K. LimT. K. Lim. 2016. Edible Medicinal and Non-Medicinal Plants. Edible Medicinal and Non-Medicinal Plants
147
196
.
Jerome Sarris, Patricia L. Gerbarg, Richard P. Brown & Philip R. Muskin. 2015. Psychiatry. Psychiatry
2261
2290
.
Xuesen Li, Xia Xu, Tao Ji, Zhongbo Liu, Mai Gu, Bang H. Hoang & Xiaolin Zi. (2014) Dietary feeding of flavokawain A, a Kava chalcone, exhibits a satisfactory safety profile and its association with enhancement of phase II enzymes in mice. Toxicology Reports 1, pages 2-11.
Crossref
Crossref
Adejuwon Adewale Adeneye. 2014. Toxicological Survey of African Medicinal Plants. Toxicological Survey of African Medicinal Plants
99
133
.
. 2013. Principles and Practice of Phytotherapy. Principles and Practice of Phytotherapy
353
961
.
Anthony Rowe & Iqbal Ramzan. (2012) Are Mould Hepatotoxins Responsible for Kava Hepatotoxicity?. Phytotherapy Research 26:11, pages 1768-1770.
Crossref
Crossref
Rolf Teschke, Jerome Sarris & Isaac Schweitzer. (2012) Kava hepatotoxicity in traditional and modern use: the presumed Pacific kava paradox hypothesis revisited. British Journal of Clinical Pharmacology 73:2, pages 170-174.
Crossref
Crossref
Danielle D. Jandial, Anne R. Simoneau & Xiaolin Zi. 2012. Novel Apoptotic Regulators in Carcinogenesis. Novel Apoptotic Regulators in Carcinogenesis
189
204
.
Joanne Barnes. 2011. Stephens' Detection and Evaluation of Adverse Drug Reactions. Stephens' Detection and Evaluation of Adverse Drug Reactions
645
683
.
Mamta Behl, Abraham Nyska, Rajendra S. Chhabra, Gregory S. Travlos, Laurene M. Fomby, Barney R. Sparrow, Milton R. Hejtmancik & Po C. Chan. (2011) Liver toxicity and carcinogenicity in F344/N rats and B6C3F1 mice exposed to Kava Kava. Food and Chemical Toxicology 49:11, pages 2820-2829.
Crossref
Crossref
Rolf Teschke & Vincent Lebot. (2011) Proposal for a Kava Quality Standardization Code. Food and Chemical Toxicology 49:10, pages 2503-2516.
Crossref
Crossref
Line R. Olsen, Mark P. Grillo & Christian Skonberg. (2011) Constituents in Kava Extracts Potentially Involved in Hepatotoxicity: A Review. Chemical Research in Toxicology 24:7, pages 992-1002.
Crossref
Crossref
Jonathan D. Baker. (2011) Tradition and toxicity: Evidential cultures in the kava safety debate. Social Studies of Science 41:3, pages 361-384.
Crossref
Crossref
George A. Asare, A. Sittie, K. Bugyei, Ben A. Gyan, Samuel Adjei, Phyllis Addo, Edwin K. Wiredu, Alex K. Nyarko, Lydia S. Otu-Nyarko & David Nana Adjei. (2011) Acute toxicity studies of Croton membranaceus root extract. Journal of Ethnopharmacology 134:3, pages 938-943.
Crossref
Crossref
Gordon Fuller. 2011. New Food Product Development. New Food Product Development
443
472
.
Anthony Rowe, Lillian Yuan Zhang & Iqbal Ramzan. (2011) Toxicokinetics of Kava. Advances in Pharmacological Sciences 2011, pages 1-6.
Crossref
Crossref
LUCIE RYCHETNIK & CHRISTINE M. MADRONIO. (2011) The health and social effects of drinking water-based infusions of kava: A review of the evidence. Drug and Alcohol Review 30:1, pages 74-83.
Crossref
Crossref
Rolf Teschke, Jerome Sarris & Vincent Lebot. (2011) Kava hepatotoxicity solution: A six-point plan for new kava standardization. Phytomedicine 18:2-3, pages 96-103.
Crossref
Crossref
Rolf Teschke. (2010) Kava hepatotoxicity: pathogenetic aspects and prospective considerations. Liver International 30:9, pages 1270-1279.
Crossref
Crossref
Stacy S. ShordKanan Shah & Alvina Lukose. (2009) Drug—Botanical Interactions: A Review of the Laboratory, Animal, and Human Data for 8 Common Botanicals. Integrative Cancer Therapies 8:3, pages 208-227.
Crossref
Crossref
Jerome SarrisDavid J. Kavanagh. (2009) Kava and St. John's Wort: Current Evidence for Use in Mood and Anxiety Disorders. The Journal of Alternative and Complementary Medicine 15:8, pages 827-836.
Crossref
Crossref
Rolf Teschke, Alexander Genthner & Albrecht Wolff. (2009) Kava hepatotoxicity: Comparison of aqueous, ethanolic, acetonic kava extracts and kava–herbs mixtures. Journal of Ethnopharmacology 123:3, pages 378-384.
Crossref
Crossref
Lei Guo, Quanzhen Li, Qingsu Xia, Stacey Dial, Po-Chuen Chan & Peter Fu. (2009) Analysis of gene expression changes of drug metabolizing enzymes in the livers of F344 rats following oral treatment with kava extract. Food and Chemical Toxicology 47:2, pages 433-442.
Crossref
Crossref
Stefan U. Christl, Axel Seifert & Dirk Seeler. (2009) Toxic Hepatitis After Consumption of Traditional Kava Preparation. Journal of Travel Medicine 16:1, pages 55-56.
Crossref
Crossref
Thomas E. Johnson, Fekadu Kassie, M. Gerard O'Sullivan, Mesfin Negia, Timothy E. Hanson, Pramod Upadhyaya, Peter P. Ruvolo, Stephen S. Hecht & Chengguo Xing. (2008)
Chemopreventive Effect of Kava on 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone plus Benzo[
a
]pyrene–Induced Lung Tumorigenesis in A/J Mice
. Cancer Prevention Research 1:6, pages 430-438.
Crossref
Crossref
Donald G. Barceloux. 2008. Medical Toxicology of Natural Substances. Medical Toxicology of Natural Substances
525
531
.
Bill J. Gurley, Ashley Swain, Martha A. Hubbard, D. Keith Williams, Gary Barone, Faith Hartsfield, Yudong Tong, Danielle J. Carrier, Shreekar Cheboyina & Sunil K. Battu. (2008)
Clinical assessment of CYP2D6‐mediated herb–drug interactions in humans: Effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and
Echinacea
. Molecular Nutrition & Food Research 52:7, pages 755-763.
Crossref
Crossref
Shivakumar Chitturi & Geoffrey C Farrell. (2008) Hepatotoxic slimming aids and other herbal hepatotoxins. Journal of Gastroenterology and Hepatology 23:3, pages 366-373.
Crossref
Crossref
Paul Whittaker, Jane J. Clarke, Richard H.C. San, Joseph M. Betz, Harold E. Seifried, Lowri S. de Jager & Virginia C. Dunkel. (2008) Evaluation of commercial kava extracts and kavalactone standards for mutagenicity and toxicity using the mammalian cell gene mutation assay in L5178Y mouse lymphoma cells. Food and Chemical Toxicology 46:1, pages 168-174.
Crossref
Crossref
Lawrence D. Rosen & Cora Collette Breuner. (2007) Primary Care from Infancy to Adolescence. Pediatric Clinics of North America 54:6, pages 837-858.
Crossref
Crossref
E. Ernst. (2007)
A re‐evaluation of kava (
Piper methysticum
)
. British Journal of Clinical Pharmacology 64:4, pages 415-417.
Crossref
Crossref
Jerome Sarris. (2007) Herbal medicines in the treatment of psychiatric disorders: a systematic review. Phytotherapy Research 21:8, pages 703-716.
Crossref
Crossref
William H. RichardsonIIIIII, Cheryl M. Slone & Jill E. Michels. (2007) Herbal Drugs of Abuse: An Emerging Problem. Emergency Medicine Clinics of North America 25:2, pages 435-457.
Crossref
Crossref
Natasha P. Clayton, Katsuhiko Yoshizawa, Grace E. Kissling, Leo T. Burka, Po-Chuen Chan & Abraham Nyska. (2007) Immunohistochemical analysis of expressions of hepatic cytochrome P450 in F344 rats following oral treatment with kava extract. Experimental and Toxicologic Pathology 58:4, pages 223-236.
Crossref
Crossref
Vikas Kumar. (2006) Potential medicinal plants for CNS disorders: an overview. Phytotherapy Research 20:12, pages 1023-1035.
Crossref
Crossref
R. Brent Furbee, Kevin S. Barlotta, Melrose Kanku Allen & Christopher P. Holstege. (2006) Hepatotoxicity Associated with Herbal Products. Clinics in Laboratory Medicine 26:1, pages 227-241.
Crossref
Crossref
Malcolm Lader, Daniel P. Cardinali & S. R. Pandi-PerumalMarcello Spinella. 2006. Sleep and Sleep Disorders. Sleep and Sleep Disorders
297
303
.
K N Woodward. (2016) The potential impact of the use of homeopathic and herbal remedies on monitoring the safety of prescription products. Human & Experimental Toxicology 24:5, pages 219-233.
Crossref
Crossref
ALAN R. CLOUGH, PETER D'ABBS, SHEREE CAIRNEY, DENNIS GRAY, PAUL MARUFF, ROBERT PARKER & BRIDIE O'REILLY. (2009) Emerging patterns of cannabis and other substance use in Aboriginal communities in Arnhem Land, Northern Territory: a study of two communities. Drug and Alcohol Review 23:4, pages 381-390.
Crossref
Crossref
Cynthia S. Côté, Christine Kor, Jon Cohen & Karine Auclair. (2004) Composition and biological activity of traditional and commercial kava extracts. Biochemical and Biophysical Research Communications 322:1, pages 147-152.
Crossref
Crossref